Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04857411 · ClinicalTrials.gov registry record · NA
Peers LEAD Plus Healthy Living With Diabetes (HLWD)
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT04857411: Completed NA study, sponsored by University of Wisconsin, Madison.
NCT04857411 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04857411, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The specific goal of this project is to decrease diabetes-related morbidity among African Americans (AAs) in Milwaukee through the integration of Peers LEAD, a culturally-appropriate program to increase medication adherence into Healthy Living with Diabetes (HLWD), an existing diabetes self-management program.
Primary Outcome
Participant buddies will have a hemoglobin A1c greater than 8 percent at baseline. will be measured using the A1cNow+ system, the National Glycohemoglobin Standardization Program Certified, CLIA-waived, system that provides results using a finger stick test.
Interventions
- BEHAVIORAL Peers LEAD plus HLWD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2021-04-19 |
| Est. Completion | 2021-11-22 |
| Phase | NA |
What the finished NCT04857411 record still lists
NCT04857411 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Peers LEAD plus HLWD is the first listed.
NCT04857411 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04857411 about?
NCT04857411 is a clinical study titled "Peers LEAD Plus Healthy Living With Diabetes (HLWD)". The specific goal of this project is to decrease diabetes-related morbidity among African Americans (AAs) in Milwaukee through the integration of Peers LEAD, a culturally-appropriate program to increase medication adherence into Healthy Living with Diabetes (HLWD), an existing diabetes self-manageme...
What is the current status of trial NCT04857411?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2021-04-19. Estimated completion is 2021-11-22.
What interventions are being tested in trial NCT04857411?
The interventions under investigation include: Peers LEAD plus HLWD (BEHAVIORAL).
Who is sponsoring clinical trial NCT04857411?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04857411's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI